Humana Inc. (NYSE:HUM) Shares Sold by Truist Financial Corp

Truist Financial Corp lowered its stake in Humana Inc. (NYSE:HUM) by 29.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 11,479 shares of the insurance provider’s stock after selling 4,733 shares during the quarter. Truist Financial Corp’s holdings in Humana were worth $5,255,000 at the end of the most recent quarter.

Several other institutional investors have also bought and sold shares of the stock. Rakuten Securities Inc. bought a new stake in Humana in the fourth quarter worth about $25,000. Gradient Investments LLC boosted its position in Humana by 200.0% during the fourth quarter. Gradient Investments LLC now owns 60 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 40 shares during the period. Cetera Trust Company N.A bought a new stake in Humana during the fourth quarter worth approximately $28,000. Nvwm LLC boosted its position in Humana by 41.0% during the third quarter. Nvwm LLC now owns 86 shares of the insurance provider’s stock worth $42,000 after purchasing an additional 25 shares during the period. Finally, Operose Advisors LLC bought a new stake in Humana during the third quarter worth approximately $56,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on HUM shares. Argus lowered Humana from a “buy” rating to a “hold” rating in a report on Wednesday, March 13th. Oppenheimer cut their price target on Humana from $415.00 to $370.00 and set an “outperform” rating for the company in a report on Thursday, April 25th. Barclays cut their price target on Humana from $356.00 to $310.00 and set an “equal weight” rating for the company in a report on Tuesday, April 2nd. UBS Group cut their price target on Humana from $334.00 to $326.00 and set a “neutral” rating for the company in a report on Thursday, April 25th. Finally, Jefferies Financial Group cut their price target on Humana from $411.00 to $381.00 and set a “buy” rating for the company in a report on Monday, April 22nd. Eleven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $424.50.

Humana Stock Down 0.1 %

HUM stock opened at $320.54 on Monday. The company has a current ratio of 1.67, a quick ratio of 1.67 and a debt-to-equity ratio of 0.77. The firm has a market capitalization of $38.63 billion, a PE ratio of 19.96, a PEG ratio of 1.86 and a beta of 0.49. Humana Inc. has a 1-year low of $298.61 and a 1-year high of $541.21. The business’s 50 day simple moving average is $324.12 and its 200 day simple moving average is $387.61.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping analysts’ consensus estimates of $6.12 by $1.11. The business had revenue of $29.61 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a return on equity of 17.76% and a net margin of 1.82%. The firm’s revenue was up 10.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $9.38 EPS. As a group, research analysts anticipate that Humana Inc. will post 16.18 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.10%. The ex-dividend date is Friday, June 28th. Humana’s dividend payout ratio is 22.04%.

Insider Buying and Selling at Humana

In other news, Director Jorge S. Mesquita acquired 545 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were purchased at an average cost of $367.09 per share, with a total value of $200,064.05. Following the acquisition, the director now directly owns 2,578 shares in the company, valued at approximately $946,358.02. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.32% of the company’s stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.